Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Return on Capital Employed: 2021-2025

Historic Return on Capital Employed for Arcutis Biotherapeutics (ARQT) over the last 4 years, with Sep 2025 value amounting to -0.15%.

  • Arcutis Biotherapeutics' Return on Capital Employed rose 53.00% to -0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.15%, marking a year-over-year increase of 53.00%. This contributed to the annual value of -0.49% for FY2024, which is 21.00% up from last year.
  • As of Q3 2025, Arcutis Biotherapeutics' Return on Capital Employed stood at -0.15%, which was up 58.44% from -0.35% recorded in Q2 2025.
  • Arcutis Biotherapeutics' 5-year Return on Capital Employed high stood at -0.15% for Q3 2025, and its period low was -1.01% during Q2 2023.
  • In the last 3 years, Arcutis Biotherapeutics' Return on Capital Employed had a median value of -0.54% in 2024 and averaged -0.61%.
  • In the last 5 years, Arcutis Biotherapeutics' Return on Capital Employed dropped by 21bps in 2023 and then soared by 57bps in 2024.
  • Arcutis Biotherapeutics' Return on Capital Employed (Quarterly) stood at -0.57% in 2021, then declined by 12bps to -0.68% in 2022, then decreased by 21bps to -0.89% in 2023, then spiked by 48bps to -0.41% in 2024, then soared by 53bps to -0.15% in 2025.
  • Its last three reported values are -0.15% in Q3 2025, -0.35% for Q2 2025, and -0.48% during Q1 2025.